Sorted By:

Relevance


Some Insured Patients Still Skipping Care Because Of High Costs

Access Better Coverage  |  From Our Network

"One in four adults who were fully insured for the whole year still reported they went without some needed medical care because they couldn't afford it," Mitts says.
http://www.accessbettercoverage.org/social-news/some-insured-patients-still-skipping-care-because-of-high-costs

Medicare Monday: What they are saying about MedPAC’s recommendations

PhRMA  |  Blog Post

” Morning Consult reported in April that more than 250 groups asked MedPAC not to move forward with the proposals.
http://catalyst.phrma.org/medicare-monday-what-they-are-saying-about-medpacs-recommendations

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

Methodology The analysis reviewed the prevalence of combined medical and pharmacy deductibles, compared standard types of plan designs for Silver plans and employer-sponsored plans, assessed member  cost sharing as a result of combined deductibles, and modeled the difference in actuarial value by benefit category as a result of combined deductibles.
https://www.phrma.org/press-release/many-patients-with-exchange-coverage-to-pay-more-than-twice-as-much-out-of-pocket-for-prescriptions-compared-to-employer-plans

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

PhRMA  |  Blog Post

Margolis professor of business, medicine and policy and director, Duke-Margolis Center for Health Policy at Duke University View past events of The Value Collaborative here.  
http://catalyst.phrma.org/janssen-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care

PhRMA Statement on 2017 Special 301 Report

PhRMA  |  Press Release

India and Indonesia do not even provide patents for many kinds of new medicines.
https://www.phrma.org/press-release/phrma-statement-on-2017-special-301-report

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Contrary to media reports, PhRMA did not previously endorse the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 or advocate for its enactment.
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

Compulsory licensing: A misused and abused international trade law

PhRMA  |  Blog Post

In one instance, India granted a compulsory license to a homegrown generic drug-maker for the production and sale of a patented oncology medicine in part because it was not manufactured in India.
http://catalyst.phrma.org/compulsory-licensing-a-misused-and-abused-international-trade-law

Stephen J. Ubl

PhRMA  |  Biography

He is routinely recognized as one of Washington’s most effective advocates, and, in 2016, was named one of the Top 20 Most Influential People in Healthcare by Modern Healthcare, a Top Lobbyist by The Hill and a top health influencer by Medical Marketing & Media and PR Week magazines.
https://www.phrma.org/biography/stephen-j-ubl

Brian Reid

PhRMA  |  Biography

He has extensive new media experience, which includes four years as a blogger on family issues for the Washingtonpost.com where he wrote for the “On Parenting” and “On Balance” blog.
https://www.phrma.org/biography/brian-reid

Medicare Monday: New research finds drugs not a key driver of Medicare Part B costs

PhRMA  |  Blog Post

Looking behind the headlines to see what is actually driving health care costs is important (Check out our recent discussion of MedPAC’s analysis of Medicare drug costs here, here and here). 
http://catalyst.phrma.org/medicare-monday-new-research-finds-drugs-not-a-key-driver-of-medicare-part-b-costs

Using setbacks as stepping stones in Alzheimer’s research

PhRMA  |  Blog Post

Despite this perseverance, Alzheimer’s remains one of the most vexing scientific and medical challenges of our time.
http://catalyst.phrma.org/catalyst-dev/the-science-of-hope-using-setbacks-as-stepping-stones-in-alzheimers-research-0

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

PhRMA  |  Press Release

Several pieces of research have noted this impact on patients, including the Medicare Payment Advisory Commission in its March 2017 Report to Congress and a 2017 Magellan Rx Management report on patients with commercial insurance.
https://www.phrma.org/press-release/new-analysis-340b-program-shifting-delivery-of-physician-administered-medicines-to-more-expensive-hospital-settings

PhRMA Statement Regarding FDA Oversight of Promotion Online

PhRMA  |  Press Release

Clearly, social media can be used to discuss new medical advances in appropriate ways that benefit patients and healthcare professionals, and improve the public health."
https://www.phrma.org/press-release/phrma-statement-regarding-fda-oversight-of-promotion-online

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

PhRMA  |  Press Release

He always reaches his maximum out-of-pocket limit on his medical and pharmacy expenses early in the year.
https://www.phrma.org/press-release/sharing-negotiated-discounts-could-save-patients-more-than-800-annually-and-would-increase-premiums-about-1-percent

Ours is a Global Community

PhRMA  |  Blog Post

Accepting the recognition on behalf of all of us at PhRMA, President and CEO John Castellani released a statement reading, in part, "Through working with other organizations like Rotary International, we will continue our dedication in broadening patient access to safe and effective medicines to help patients around the world fight disease."
http://catalyst.phrma.org/ours-is-a-global-community

Sir Andrew Witty

PhRMA  |  Biography

In 2003, he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star.
https://www.phrma.org/biography/sir-andrew-witty

ICYMI: Multi-stakeholder group recommended changes to support value-driven health care

PhRMA  |  Blog Post

Read the full white paper summarizing these recommendations here.
http://catalyst.phrma.org/icymi-multi-stakeholder-group-recommended-changes-to-support-value-driven-health-care

Melissa Hogan

PhRMA  |  Biography

She is the author of the e-book Calmer: Medical Events with Cognitively Impaired Children (2012) which shares strategies for preventing medical trauma in children with chronic medical conditions.
https://www.phrma.org/biography/melissa-hogan

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

Methodology The analysis reviewed the prevalence of combined medical and pharmacy deductibles, compared standard types of plan designs for Silver plans and employer-sponsored plans, assessed member  cost sharing as a result of combined deductibles, and modeled the difference in actuarial value by benefit category as a result of combined deductibles.
https://www.phrma.org

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Strengthening India’s IP: Findings from a recent study demonstrate that robust intellectual property protections in India would expand the research and development intensity of its key industries, as well as its economy.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-november-6-2015

Ask About Adherence: One tool for synchronizing and simplifying your medication routine

PhRMA  |  Blog Post

Here are some additional resources to check out to learn more about the importance of medication adherence and see if a program like med sync is right for you and your family.
http://catalyst.phrma.org/ask-about-adherence-one-tool-for-synchronizing-and-simplifying-your-medication-routine

Trading fair means upholding the law: A focus on patents

PhRMA  |  Blog Post

Additionally, India, Indonesia and Argentina do not grant any patent protection to many new medicines researched and developed in the United States.
http://catalyst.phrma.org/trading-fair-means-upholding-the-law-a-focus-on-patents

PhRMA Statement on PCAST Innovation Report

PhRMA  |  Press Release

“This report couldn’t have come at a better time andwe look forward to having discussions with members of the new Congress and the Administration on steps we can take to help ensure the U.S. remains the world leader in medical innovation.”
https://www.phrma.org/press-release/phrma-statement-on-pcast-innovation-report

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

PhRMA  |  Press Release

Members of the media are welcome to visit the exhibit and check out the 360° video during the Spotlight Health conference.
https://www.phrma.org

PhRMA Statement on Misleading Reports About Price Growth

PhRMA  |  Press Release

Unfortunately, medicines are always looked at as a cost and never seen as a savings – even though medicines often reduce unnecessary hospitalizations, help avoid costly medical procedures and increase productivity through better prevention and management of chronic diseases.”
https://www.phrma.org/press-release/phrma-statement-on-misleading-reports-about-price-growth

You have reviewed the first 200 results out of 1046. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 12 next